Back

Differential diagnosis of hypertrophic cardiomyopathy, fabry cardiomyopathy and transthyretin cardiac amyloidosis: insights from right ventricular strain imaging echocardiography

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: Imaging of the hypertrophied left ventricle Tissue Doppler, Speckle Tracking and Strain Imaging EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Emidio Mata

Unidade Local de Saude do Alto Ave - Hospital Senhora da Oliveira - Guimaraes, Creixomil (Portugal)

4 More presentations in this session

Presentation thumbnail
Right atrial strain in Anderson-Fabry disease
Doctor R. Lillo (Rome, IT)
Abstract Slides
Presentation thumbnail
Abnormal right ventricular strain predicts poor prognosis in transthyretin amyloidosis
Doctor S. Istratoaie (Cluj Napoca, RO)
Abstract Slides
Presentation thumbnail
Mavacamten reduces left ventricular mechanical dispersion in hypertrophic obstructive cardiomyopathy
Doctor B. Ozbay (Pittsburgh, US)
Abstract Slides
Presentation thumbnail
The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment
Doctor V. Nagy (Szeged, HU)
Abstract Slides

Access the full session

Session thumbnail
Imaging of the hypertrophied left ventricle

The Event

Event poster

EuroEcho-Imaging 2024

11 December - 13 December 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources